Where does Embold Health, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Embold Health, Inc. ranks #46,467 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Embold Health, Inc. hold?

Embold Health, Inc. holds 5 US utility patents granted between 2020 and 2024, spanning 3 technology areas.

What is Embold Health, Inc.'s Innovation Score?

Embold Health, Inc. has an Innovation Score of 21.3 out of 100 (8th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Embold Health, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Embold Health, Inc..

What does claim depth mean for Embold Health, Inc.'s patents?

Embold Health, Inc.'s patents average 7.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Embold Health, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Embold Health, Inc.

Q: What technology areas does Embold Health, Inc. focus on?

Embold Health, Inc.'s top technology area is G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data) with 2 patents, ranking #1,713 of 3,149 assignees active in that subclass. Grants appear in 3 CPC subclasses total.

USPTO PatentsView assignee record - 5 granted patents across 3 technology areas, recorded in grant years 2020–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Embold ranks #46,467 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 3 technology areas.

#46,467
of 49,997 US assignees by volume: 8th percentile
by Innovation Score (21.3/100): 7.6
avg claims per patent

USPTO PatentsView assignee plate

Corpus R46467 · US Corporation #46,467 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 5 grants
BOTTOM-DECILE #46,467/49,997
PHOTO-FINISH Ellume Pty
CPC-NARROW G16H · 3 areas
INNOV-THIN 21.3/100
CLAIMS-SPARSE 7.6 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2020–2024 · 5y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Ellume Pty Ltd (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Embold’s 21.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.2 pts (29%) Velocity 4.4 pts (21%) Breadth 6.1 pts (29%) Claim depth 4.6 pts (22%)

Qualcomm Incorporated · highest

85
Embold Health · this assignee

21
3D Lighting… · lowest

7

What this shows Embold's Innovation Score is 21.3/100 (8th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Embold?

Each dot is one of Embold’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Embold’s own 7.6 claims/patent is at or below the 13.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Embold vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Embold's grants concentrate

Embold Health, Inc. is a focused PatentsView assignee: 3 CPC subclasses with 40% of grants classified under G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data). Peak complete grant year is 2021 (2 grants) versus a trough of 1 in 2020. By volume, Embold sits between Ellume Pty Ltd and Emergency Medical Innovation LLC.

Embold's three-year grant acceleration

Embold Health, Inc. shows 2 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Ellume Pty

5
Elopak ASA

5
Embark Enterprises

5
Embo Medical

5
Embrient

5
Emcara Gas Develo…

5
Emergex

5
Emergency Medical…

5
Embold Health ◀

5

What this shows Embold holds 5 patents at rank #46,563, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Embold

By rank, the assignees closest to #46,563 in granted patent volume.

Leaders in G16H (Healthcare Informatics)

Other assignees with the most granted patents in Embold's primary technology class.

Embold's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

21 8th percentile higher than 8% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Embold Health, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	1	20.0%
2021	2	40.0%
2024	2	40.0%

Which technologies does Embold Health, Inc. patent most?

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 2

G06F - Electric Digital Data Processing 1

H04L - Transmission OF Digital Information, e.g. Telegraphic Communication 1

Top 3 of 3 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Embold Health, Inc.'s patent record in context - here's where to go next.

Embold Health, Inc.'s lead technology class is G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data), 40% of its portfolio - see every assignee active in that class. Explore G16H
Ranked #46,467 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Embold Health, Inc. against Ellume Pty Ltd, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 21.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.